| Michelle Swan, ARNP, PMHNP-BC | |
|
515 Grand Ave, Ames, IA 50010-6079 | |
| (888) 336-9661 | |
| Not Available |
| Full Name | Michelle Swan |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Psychiatric/mental Health |
| Location | 515 Grand Ave, Ames, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801578646 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LP0808X | Nurse Practitioner - Psychiatric/mental Health | G175744 (Iowa) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michelle Swan, ARNP, PMHNP-BC 1203 W Mamie Eisenhower Ave, Boone, IA 50036-3920 Ph: (515) 230-0565 | Michelle Swan, ARNP, PMHNP-BC 515 Grand Ave, Ames, IA 50010-6079 Ph: (888) 336-9661 |
News Archive
Kaiser Health News provides a fresh take on health policy developments with "Failure To Launch?" by Gary McCoy.
ev3 Inc. today announced the completion of patient enrollment in the DURABILITY II trial, a prospective, multi-center, single-arm study evaluating the EverFlex® Self-Expanding Stent System for the treatment of superficial femoral artery (SFA) and proximal popliteal lesions. The DURABILITY II study will support a planned Premarket Approval (PMA) filing with the U.S. Food and Drug Administration to obtain approval of the EverFlex Self-Expanding Stent System for use in the SFA.
Synedgen, a company leveraging its proprietary glycomics technology platform to develop glycopolymer-based therapeutics for infectious and inflammatory conditions, today announced the market launch of Moisyn Rinse for the treatment of the symptoms of xerostomia, or dry mouth. Moisyn Rinse is being distributed by Prisyna, the oral care division of Synedgen.
Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today that it has filed an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) to begin a Phase 2 clinical trial of its orally ingested insulin candidate, ORMD-0801.
› Verified 9 days ago
Carl Markley, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 420 Kellogg Ave, Ames, IA 50010 Phone: 515-233-3141 | |
Emily Black, ARNP PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 600 5th St, Ames, IA 50010 Phone: 515-233-1122 | |
Alyson Vosberg, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3815 Stange Rd, Ames, IA 50010 Phone: 515-956-4050 | |
Mary Ramen, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Isu Thomas B. Thielen Student Health Center, Union & Sheldon, Ames, IA 50011 Phone: 515-294-5801 Fax: 515-294-7180 | |
Lindsay Eileen Hannapel, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2530 Chamberlain St, Ames, IA 50014 Phone: 877-849-0763 | |
Marie Burrows, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Iowa State University, 2260 Thielen Student Health Center, Ames, IA 50011 Phone: 515-294-7265 Fax: 515-294-5457 | |
Jennifer K Britten, A.R.N.P. Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1816 Philadelphia St, Ames, IA 50010 Phone: 515-232-2500 Fax: 515-663-4131 |